Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair DeficiencyÉric Bouffet, Uri Tabori, Nataliya Zhukova et al.|Journal of Clinical Oncology|2016Cited by 867
Comprehensive Analysis of Hypermutation in Human CancerBrittany Campbell, Melyssa Aronson, Nicholas Light et al.|Cell|2017Cited by 795
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerKim N., Celio Kussumoto, Dana E. Rathkopf et al.|Journal of Clinical Oncology|2023Cited by 317
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trialK.N. Chi, Eleni Efstathiou, Shahneen Sandhu et al.|Annals of Oncology|2023Cited by 195
DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human CellsJiil Chung, Cynthia Hawkins, Yosef E. Maruvka et al.|Cancer Discovery|2020Cited by 85